SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-127353
Filing Date
2016-06-15
Accepted
2016-06-15 16:08:44
Documents
14
Period of Report
2016-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-13380_18k.htm 8-K 78215
2 EX-2.1 a16-13380_1ex2d1.htm EX-2.1 1319061
3 EX-3.1 a16-13380_1ex3d1.htm EX-3.1 115044
4 EX-10.1 a16-13380_1ex10d1.htm EX-10.1 73011
5 EX-10.2 a16-13380_1ex10d2.htm EX-10.2 662766
6 EX-10.3 a16-13380_1ex10d3.htm EX-10.3 309436
7 EX-10.4 a16-13380_1ex10d4.htm EX-10.4 56226
8 EX-10.5 a16-13380_1ex10d5.htm EX-10.5 49026
9 EX-10.6 a16-13380_1ex10d6.htm EX-10.6 49272
10 EX-99.1 a16-13380_1ex99d1.htm EX-99.1 41808
11 EX-99.2 a16-13380_1ex99d2.htm EX-99.2 96909
12 EX-99.3 a16-13380_1ex99d3.htm EX-99.3 22049
13 GRAPHIC g133801mo01i001.gif GRAPHIC 2209
14 GRAPHIC g133801mo03i001.jpg GRAPHIC 1928
  Complete submission text file 0001104659-16-127353.txt   2880326
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34921 | Film No.: 161715387
SIC: 2834 Pharmaceutical Preparations